After-Hours Movers: Cassava Sciences Surges on Insider Buy, Agilent Gains Post EPS

This post was originally published on this site

Cassava Sciences (NASDAQ:SAVA) 20% HIGHER; Director Stanford Robertson bought $2 million in stock.

Blue Apron Holdings Inc (NYSE:APRN)18% HIGHER; adds to intra-day gains.

AerSale Corp (NASDAQ:ASLE7% LOWER; announced that certain of its stockholders, including affiliates of Leonard Green & Partners, L.P. (the Selling Stockholders) intend to offer for sale in an underwritten secondary offering 4,250,000 shares of common stock of AerSale pursuant to a shelf registration statement

Canoo Inc (NASDAQ:GOEV) 6% HIGHER; CEO Tony Aquila bought 200K shares.

Agilent Technologies (NYSE:A) 6% HIGHER; reported Q3 EPS of $1.34, $0.14 better than the analyst estimate of $1.20. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.64 billion. Agilent Technologies sees Q4 2022 EPS of $1.38-$1.40, versus the consensus of $129.00. Agilent Technologies sees Q4 2022 revenue of $1.75-1.775 billion, versus the consensus of $1.71 billion.

Option Care Health, Inc. (NASDAQ:OPCH) 5% LOWER; announced today that an affiliate of Walgreens Boots Alliance (NASDAQ:WBA) has agreed to sell 11,000,000 shares of the Company’s common stock in an underwritten secondary offering.

Bed Bath & Beyond Inc. (NASDAQ:BBBY) 5% HIGHER; adds to recent gains, including 29% intra-day gain.

Quanterix (NASDAQ:QTRX) 4% HIGHER; The CEO and CFO both bought stock.

Jack Henry & Associates Inc (NASDAQ:JKHY4% LOWER; reported Q4 EPS of $1.10, $0.10 better than the analyst estimate of $1.00. Revenue for the quarter came in at $482.7 million versus the consensus estimate of $480.3 million. Jack Henry sees FY2023 EPS of $5.05-$5.09, versus the consensus of $5.23. Jack Henry sees FY2023 revenue of $2.08-2.09 billion, versus the consensus of $2.08 billion.

Oak Street Health Inc (NYSE:OSH) 4% LOWER; announced the commencement of an underwritten public offering of 7,000,000 shares of its common stock by a selling stockholder.

Lulu’s Fashion Lounge Holdings Inc (NASDAQ:LVLU4% HIGHER; reported Q2 EPS of $0.15, $0.07 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $131.5 million versus the consensus estimate of $133.18 million. Lulu’s Fashion Lounge Holdings, Inc. reaffirms Q3 2022 revenue of $440-480 million.

Unity Biotechnology Inc (NASDAQ:UBX4% LOWER; announced that it has commenced a proposed underwritten public offering of $25.0 million of shares of its common stock

QuickLogic Corporation (NASDAQ:QUIK2% HIGHER; reported Q2 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $4.47 million.